Program Identifies Families at High Risk for Colorectal Cancer

Key points
- UT Southwestern Medical Center has developed a new lifesaving genetic screening program for families at high risk of contracting colorectal cancer, a deadly yet highly preventable form of cancer.
- The joint effort between UT Southwestern and Parkland Memorial Hospital allows doctors to screen the tumors of colorectal cancer patients younger than 70, and uterine cancer patients younger than 55, to determine if there is a high risk for a genetic cancer predisposition syndrome.
- “If we can bring in family members of those who have been diagnosed, we have a chance to catch their colon cancer early and even prevent it,” said Dr.
- Through this unusual tumor-testing protocol, 11 patients have already been identified with Lynch syndrome, one of the more common inherited conditions, accounting for 3 percent to 5 percent of all colon cancers.
UT Southwestern Medical Center has developed a new lifesaving genetic screening program for families at high risk of contracting colorectal cancer, a deadly yet highly preventable form of cancer.
The joint effort between UT Southwestern and Parkland Memorial Hospital allows doctors to screen the tumors of colorectal cancer patients younger than 70, and uterine cancer patients younger than 55, to determine if there is a high risk for a genetic cancer predisposition syndrome. If a predisposition syndrome is found, patients are encouraged to bring in as many family members as possible for testing.
“If we can bring in family members of those who have been diagnosed, we have a chance to catch their colon cancer early and even prevent it,” said Dr. Samir Gupta, assistant professor of internal medicine at UT Southwestern and head of the high-risk colorectal cancer clinic started at Parkland this year.
Through this unusual tumor-testing protocol, 11 patients have already been identified with Lynch syndrome, one of the more common inherited conditions, accounting for 3 percent to 5 percent of all colon cancers. The colorectal cancer clinic’s aim is to test up to 50 family members among the 11 patients for the same condition. Those with Lynch syndrome have an 80 percent risk of contracting colorectal cancer, up to 60 percent risk for uterine cancer and higher than average risks for other cancer types.
Colorectal cancer is the second-leading cancer killer after lung cancer, according to the American Cancer Society. In light of this, the Cancer Prevention and Research Institute of Texas recently awarded UT Southwestern a $1.5 million grant to further its genetic testing efforts. The grant, whose principal investigator is Dr. David Euhus, professor of surgical oncology, funds family history assessments and genetic counseling among low-income and minority communities in Dallas and five surrounding counties, focusing on those at risk for Lynch and hereditary breast-ovarian cancer syndromes.
“If a parent has Lynch syndrome, there’s a 50 percent chance one of their kids will also get it,” said Linda Robinson, genetic counselor supervisor at UT Southwestern. “We’re sometimes the first people telling them they’re not going to die of cancer. We know what it’s caused by, and we can prevent it.”
Although hereditary colorectal cancer is rare, its family impact can be widespread. Cancer tends to develop rapidly in those with Lynch syndrome and is often undiagnosed until the disease is advanced. But with early screenings and monitoring, the syndrome does not have to be a death sentence.
“I think I’ll live a long time,” said Regina Ontiveroz, a 34-year-old Flower Mound woman who was diagnosed with Lynch syndrome through a blood test at UT Southwestern last year.
Colon, or colorectal, cancer is cancer that starts in the large intestine (colon) or the rectum (end of the colon).
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsLow levels of serum bilirubin spell higher lung cancer risk for male smokers
Elevated levels of bilirubin in the blood get attention in the clinic because they often indicate that something has gone wrong with the liver. Now researchers have found that male smokers with low levels of the…
8 April 2013
NewsMoffitt Cancer Center researchers study use of dasatinib for patients with high-risk MDS
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic…
21 March 2013
NewsCopper depletion therapy keeps high-risk triple-negative breast cancer at bay
An anti-copper drug compound that disables the ability of bone marrow cells from setting up a "home" in organs to receive and nurture migrating cancer tumor cells has shown surprising benefit in one of the most…





